Learning Objectives:

  • Learning Objective 1: Identify maternal and fetal risks for pregnancy in patients with sickle cell disease.
  • Learning Objective 2: Discuss evidence on trends in contraception use and contraception counseling in patients with sickle cell disease.
  • Learning Objective 3: Describe the U.S. Medical Eligibility Criteria for contraceptive use and how to utilize them in specific clinical situations.
Session date: 
Wednesday, November 4, 2020 - 2:00pm to 3:00pm
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Katarzyna Kadela, MD